Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cape Girardeau, MO
NPI
1194109041
Since 2015
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
211 Saint Francis Dr Ste 32121
Cape Girardeau, MO, 63703
Phone (573) 339-8718
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
1,644 services
Medicare patients, 2024
413
Average age 70
Drug cost, 2024
$2.9M
6,274 prescriptions
Company payments, 2025
$1,419
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rahul Thampi was code 99214 (office e&m - established), 428 times for 285 patients. In total Rahul Thampi billed 1,644 services in 11 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 428 | 285 | $73.47 | $31K |
| 99214 Office E&M - Established | Office | 291 | 234 | $79.62 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 276 | 209 | $12.62 | $3,482 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 172 | 147 | $10.90 | $1,875 |
| 95251 Test - Miscellaneous | Facility | 151 | 92 | $26.38 | $3,983 |
| 95251 Test - Miscellaneous | Office | 102 | 77 | $25.34 | $2,584 |
| 83036 Blood Count | Office | 72 | 65 | $9.28 | $668 |
| 99204 Office E&M - New | Facility | 58 | 58 | $101.72 | $5,900 |
| 99204 Office E&M - New | Office | 34 | 34 | $103.23 | $3,510 |
| 83036 Blood Count | Facility | 17 | 17 | $8.51 | $145 |
| 10005 Other Organ Systems | Office | 14 | 14 | $92.53 | $1,295 |
| 10005 Other Organ Systems | Facility | 12 | 11 | $56.43 | $677 |
By year: 2022 $50K for 670 services; 2023 $59K for 843 services; 2024 $80K for 1,644 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 72 | 65 | $9.28 | $668 |
| 83036 Blood Count | 17 | 17 | $8.51 | $145 |
Medicare prescription drug claims, 2024
In 2024, the drug Rahul Thampi prescribed most often to Medicare patients was Levothyroxine Sodium, with 628 prescriptions and refills. In total Rahul Thampi wrote 6,274 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 628 | 1,107 | 138 | $4,398 |
| Ozempic Semaglutide | 525 | 613 | 115 | $542K |
| Jardiance Empagliflozin | 447 | 588 | 88 | $343K |
| Mounjaro Tirzepatide | 437 | 490 | 81 | $518K |
| Atorvastatin Calcium Generic | 365 | 666 | 102 | $1,932 |
| Trulicity Dulaglutide | 294 | 330 | 58 | $321K |
| Rosuvastatin Calcium Generic | 235 | 443 | 60 | $2,397 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 213 | 388 | 68 | $21K |
| Ezetimibe Generic | 179 | 245 | 36 | $2,973 |
| Farxiga Dapagliflozin Propanediol | 160 | 184 | 28 | $87K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 140 | 204 | 33 | $90K |
| Synthroid Levothyroxine Sodium | 139 | 187 | 33 | $7,688 |
| Metformin Hcl Generic | 137 | 220 | 39 | $777 |
| Humalog Kwikpen U-100 Insulin Lispro | 121 | 181 | 36 | $39K |
| Glimepiride Generic | 113 | 177 | 28 | $322 |
Brand drugs: 3,722 claims; generic drugs: 2,178 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rahul Thampi $1,419 ($1,419 in general payments such as food, travel and fees) from 20 companies. The largest payer was Insulet Corporation with $201.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 12 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $160 |
| Medtronic, Inc. MDT | 5 | $126 |
| Lilly USA, LLC LLY | 9 | $121 |
| Radius Health, Inc. | 4 | $110 |
| Amgen Inc. AMGN | 7 | $109 |
| Beta Bionics, Inc. BBNX | 5 | $108 |
| Novo Nordisk Inc NVO | 5 | $105 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $68.96 |
| Averitas Pharma Inc. | 2 | $49.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.